lactic acid has been researched along with Multiple Sclerosis, Relapsing-Remitting in 2 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Multiple Sclerosis, Relapsing-Remitting: The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Juybari, KB | 1 |
| Ebrahimi, G | 1 |
| Momeni Moghaddam, MA | 1 |
| Asadikaram, G | 1 |
| Torkzadeh-Mahani, M | 1 |
| Akbari, M | 1 |
| Mirzamohammadi, S | 1 |
| Karimi, A | 1 |
| Nematollahi, MH | 1 |
| Hoffmann, P | 1 |
| Al-Ani, A | 1 |
| von Lueder, T | 1 |
| Hoffmann, J | 1 |
| Majak, P | 1 |
| Hagen, O | 1 |
| Loose, H | 1 |
| Kløw, NE | 1 |
| Opdahl, A | 1 |
| Muli Jogi, RK | 1 |
| Damodharan, K | 1 |
| Leong, HL | 1 |
| Tan, ACS | 1 |
| Chandramohan, S | 1 |
| Venkatanarasimha, NKK | 1 |
| Irani, FG | 1 |
| Patel, A | 1 |
| Gogna, A | 1 |
| Tay, KH | 1 |
| Urlings, TAJ | 1 |
| Magometschnigg, H | 1 |
| Pinker, K | 1 |
| Helbich, T | 1 |
| Brandstetter, A | 1 |
| Rudas, M | 1 |
| Nakuz, T | 1 |
| Baltzer, P | 1 |
| Wadsak, W | 1 |
| Hacker, M | 1 |
| Weber, M | 1 |
| Dubsky, P | 1 |
| Filipits, M | 1 |
| Rodrigues, R | 1 |
| Betelu, S | 1 |
| Colombano, S | 1 |
| Masselot, G | 1 |
| Tzedakis, T | 1 |
| Ignatiadis, I | 1 |
| Liu, X | 1 |
| Huang, Z | 1 |
| Qian, W | 1 |
| Zhang, Q | 1 |
| Sun, J | 1 |
| Schwartz, DL | 1 |
| Tagge, I | 1 |
| Powers, K | 1 |
| Ahn, S | 1 |
| Bakshi, R | 1 |
| Calabresi, PA | 1 |
| Todd Constable, R | 1 |
| Grinstead, J | 1 |
| Henry, RG | 1 |
| Nair, G | 1 |
| Papinutto, N | 1 |
| Pelletier, D | 1 |
| Shinohara, R | 1 |
| Oh, J | 1 |
| Reich, DS | 1 |
| Sicotte, NL | 1 |
| Rooney, WD | 1 |
2 other studies available for lactic acid and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
Evaluation of serum arsenic and its effects on antioxidant alterations in relapsing-remitting multiple sclerosis patients.
Topics: Adult; Arsenic; Case-Control Studies; Female; Humans; Lactic Acid; Male; Malondialdehyde; Middle Age | 2018 |
Topics: A549 Cells; Aged; Apoptosis; Brain; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Non-Smal | 2018 |